MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by
Nyxoah Provides General Corporate Update Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022 Mont-Saint-Guibert, Belgium
GIBRALTAR, Jan. 7, 2022 /PRNewswire/ — Crypto derivatives markets have been heating up in recent years as investors have shown
فوکنگ، چین، 6 جنوری 2022 /ژن ہوا-ایشیانیٹ/– 18 ویں فوکنگ میونسپل پیپلز کانگریس کا پہلا اجلاس اور چینی عوامی سیاسی مشاورتی کانفرنس (سی پی پی سی سی) کی 15 ویں فوکنگ میونسپل کمیٹی کا بھی پہلا اجلاس 26 سے 29 دسمبر 2021 تک منعقد ہوا۔ سی پی سی فوکنگ میونسپل کمیٹی کے شعبہ تشہیر کے […]
BOSTON and SHANGHAI, China, Jan. 06, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a
FUQING, China, Jan. 6, 2022 /Xinhua-AsiaNet/– The First Session of the 18th Fuqing Municipal People’s Congress and the First Session
Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol
OTTAWA, Ontario and CAMBRIDGE, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) — Harris, a global vertical market software provider, has
Copyright © 2024, Business Insider. All Rights Reserved.